Author:
Niu Yuchun,Ma Feng,Huang Weimei,Fang Shun,Li Man,Wei Ting,Guo Linlang
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine
Reference42 articles.
1. Haddadin S, Perry MC. History of small-cell lung cancer. Clin Lung Cancer. 2011;12(2):87–93.
2. Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park). 2008;22(13):1486–92.
3. Riaz SP, Luchtenborg M, Coupland VH, Spicer J, Peake MD, Moller H. Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer-J Iaslc. 2012;75(3):280–4.
4. Murray N, Turrisi AR. A review of first-line treatment for small-cell lung cancer. J Thorac Oncol. 2006;1(3):270-8.
5. Sarvi S, Mackinnon AC, Avlonitis N, et al. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel Neuropeptide antagonist. Cancer Res. 2014;74(5):1554–65.
Cited by
191 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献